DEF 14AThe Ballot
Neumora Therapeutics, Inc. files DEF 14A
Filed Apr 17, 2026 · 2mo ago · Accession 0001193125-26-161489
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- DEF 14A
- Filing date
- Apr 17, 2026
- Report date
- May 27, 2026
- Document
- nmra-20260417.htm
- Size
- 3.8 MB